A minimally invasive procedure designed to shrink prostate tissue with a series of blasts of steam offers men a new treatment for urinary symptoms commonly associated with enlarged prostates. The procedure, called Rezūm and developed by NxThera Inc. of Maple Grove, Minn., became widely available in the U.S. in the second half of 2016.
NxThera, Inc., a medical device company pioneering the application of its convective radiofrequency thermal technology to treat endourological conditions, today announced the Humana and Aetna health care insurance plans have joined other major insurers to provide coverage of the Rezūm® System for the minimally invasive treatment of benign prostatic hyperplasia (BPH), or enlarged prostate.
SI-BONE, Inc., an innovative medical device company that pioneered the use of the iFuse Implant System® (“iFuse”), a triangular shaped minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced that the highly respected journal Spine has published the 50th peer-reviewed iFuse paper titled Predictors of Outcome in Conservative and Minimally Invasive Surgical Management of Pain Originating from the Sacroiliac Joint – a Pooled Analysis.
Advanced ICU Care, the nation’s leading provider of high-acuity telehealth services, announced that the company is now contracted to provide acute care and monitoring to more than 1,000 acute care patient beds across more than 65 partner hospitals in the United States.